Chymoral Forte is a prescription medication, available in a number of countries across the globe. Each Chymoral Forte Tablet contains 100,000 U of Trypsin + Chymotrypsin.
Chymoral Forte Tablets – Detailed Description
Chymotrypsin is a proteolytic enzyme. Chymotrypsin is secreted by the pancreas as the inactive proenzyme chymotrypsinogen. Chymotrypsin is a serine endopeptidase that preferentially cleaves peptide bonds on the carboxyl side of amino acids with bulky hydrophobic residues, particularly tyrosine, tryptophan, phenylalanine and leucine. Chymotrypsin is effective in reducing soft tissue inflammation especially associated with trauma.
Trypsin is a serine endopeptidase that catalyzes the cleavage of peptide bonds on the carboxyl side of either arginine or lysine. Trypsin (Protease) is secreted by the pancreas as the pro-enzyme and converted to the active form in small intestine, catalyzes different enzymes important for the process of protein digestion. Clinically, Trypsin (Protease) is effective to treat symptoms of pancreatitis or other various digestive disorders
Chymoral Forte Uses – Indications
Chymoral Forte Tablets are primarily used for the treatment of acute inflammatory edema associated with Accidental and surgical trauma, Episiotomies, Intervertebral disc herniation, Sciatica, Thrombophlebitis, Vasectomies, Reduction in viscosity in mucus and sputum associated with bronchitis, rhinitis and sinusitis and reduction in various gastro-intestinal disorder.
Recommended Dosage of Chymoral Forte Tablets
For adult patients, the recommended (initial) dose of Chymoral Forte is 1 tablets 4 times a day, while the maintenance dosage is 1 tablet twice a day.
When to Avoid Chymoral Forte? (Drug Warnings)
Chymoral Forte should not be used in patients with severe hepatic insufficiency. Moreover, it should also be given cautiously to patients with renal damage or irregularities of blood clotting mechanism. Chymoral Forte should be used for a week after pulmonary hemorrhage.
Chymoral Forte – Use in Pregnancy
Chymoral Forte is available in many countries across the globe and after many years of wide spread clinical use, there is no reason to believe that it is, or may be teratogenic in humans. However it is sound medical principle to exercise precaution in prescribing any medications during the first three months of pregnancy.